info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Binimetinib
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Binimetinib treats melanoma by stopping cancer cells from growing. Melanoma is an invasive form of skin cancer. This medication comes as a tablet that you can take by mouth with a glass of water as directed.N-Nitroso Binimetinib is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Binimetinib CAS NO:NA chemically represented as 5-((4-Bromo-2-fluorophenyl)(nitroso)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide. Synchemia is the leading manufacturing and exporter of N-Nitroso Binimetinib . We supply N-Nitroso Binimetinib with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143156 |
| CAS No | NA |
| Mol.F. | C24H23N7O3 |
| Mol.Wt. | 457.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143157 |
| CAS No | NA |
| Mol.F. | C29H27N7O6 |
| Mol.Wt. | 569.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143158 |
| CAS No | NA |
| Mol.F. | C30H31N7O7 |
| Mol.Wt. | 601.62 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143159 |
| CAS No | NA |
| Mol.F. | C13H21N3O4 |
| Mol.Wt. | 283.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143160 |
| CAS No | NA |
| Mol.F. | C12H21N3O4 |
| Mol.Wt. | 271.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143161 |
| CAS No | NA |
| Mol.F. | C17H18N4O5S |
| Mol.Wt. | 390.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143162 |
| CAS No | NA |
| Mol.F. | C16H16N4O4S |
| Mol.Wt. | 360.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143163 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143164 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O2S |
| Mol.Wt. | 362.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143165 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143166 |
| CAS No | NA |
| Mol.F. | C15H14N4O2S |
| Mol.Wt. | 314.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143167 |
| CAS No | NA |
| Mol.F. | C8H7N3O2S |
| Mol.Wt. | 209.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143168 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143169 |
| CAS No | NA |
| Mol.F. | C17H18N4O3S |
| Mol.Wt. | 358.42 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143170 |
| CAS No | NA |
| Mol.F. | C17H18N4O5S |
| Mol.Wt. | 390.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143171 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O3S |
| Mol.Wt. | 378.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
